YOKNEAM ILIT, Israel, Oct. 5, 2020 /PRNewswire/ -- PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that it has received regulatory approval from the Australian Therapeutic Goods Administration (TGA) for the HemoScreen™, PixCell's hematology analyzer that offers a 5-part differential CBC...
Medow Health AI ip in another $3.5M into AI medtech capital raise Medow Health AI, the Australian health-tech company buildin...
Walk through many Australian shopping strips and there is a contradiction in plain sight. Australians are spending more mo...
Australia's reporting season delivered uneven results, sharp share price reactions and a more cautious outlook from many li...
The iPhone 18 Pro Max can cost more than many people would spend on a computer. Its appeal says as...
The Australian-born fitness brand is bringing its global competition home, with athletes from across...
Spring is here, and it's arrived warm. Sydney recorded temperatures more typical of midsummer in t...
Every Australian family with school-aged children knows the pattern. Look at an airfare, hotel ro...
Nearly half of Australian homeowners have delayed a major renovation in the past two years, accord...
Spring is here, and it's arrived warm. Sydney recorded temperatures more typical of midsummer in t...
New social and nature prescribing hubs connect locals to community activities to combat loneliness...